Open Access

MicroRNA‑650 targets inhibitor of growth 4 to promote colorectal cancer progression via mitogen activated protein kinase signaling

  • Authors:
    • Qi You
    • Huining Li
    • Yao Liu
    • Yangyang Xu
    • Susheng Miao
    • Guodong Yao
    • Yingwei Xue
    • Jingshu Geng
    • Xiaoming Jin
    • Hongxue Meng
  • View Affiliations

  • Published online on: June 6, 2018     https://doi.org/10.3892/ol.2018.8910
  • Pages: 2326-2334
  • Copyright: © You et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Colorectal cancer (CRC) is the third most common malignant disease globally and causes numerous cancer‑associated mortalities; however, the underlying molecular mechanisms remain unresolved. MicroRNAs (miRs) are endogenous noncoding RNAs that regulate post‑transcriptional gene silencing by annealing to partially complementary sequences in the 3'‑untranslated regions of target mRNAs. In the present study, expression of the tumor suppressor gene inhibitor of growth protein 4 (ING4) in cell lines was investigated using reverse transcription‑quantitative polymerase chain reaction and western blotting. miR‑650 overexpression promoted CRC cell proliferation and migration by targeting ING4 when the cells were transfected with the miR‑650 mimics. Additionally, overexpression of miR‑650 increased the epithelial‑mesenchymal transition and activation of the Ras homolog gene family member A/Ras‑related C3 botulinum toxin GTPase. Extracellular signal‑regulated kinases and p38 mitogen‑activated protein kinase signaling were markedly activated when miR‑650 was increased in CRC cells. Combined, the results indicate the mechanism underlying the miR‑650 promotion of CRC progression, and provide promising potential biomarkers for the prognosis and treatment of CRC.
View Figures
View References

Related Articles

Journal Cover

August-2018
Volume 16 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
You Q, Li H, Liu Y, Xu Y, Miao S, Yao G, Xue Y, Geng J, Jin X, Meng H, Meng H, et al: MicroRNA‑650 targets inhibitor of growth 4 to promote colorectal cancer progression via mitogen activated protein kinase signaling. Oncol Lett 16: 2326-2334, 2018
APA
You, Q., Li, H., Liu, Y., Xu, Y., Miao, S., Yao, G. ... Meng, H. (2018). MicroRNA‑650 targets inhibitor of growth 4 to promote colorectal cancer progression via mitogen activated protein kinase signaling. Oncology Letters, 16, 2326-2334. https://doi.org/10.3892/ol.2018.8910
MLA
You, Q., Li, H., Liu, Y., Xu, Y., Miao, S., Yao, G., Xue, Y., Geng, J., Jin, X., Meng, H."MicroRNA‑650 targets inhibitor of growth 4 to promote colorectal cancer progression via mitogen activated protein kinase signaling". Oncology Letters 16.2 (2018): 2326-2334.
Chicago
You, Q., Li, H., Liu, Y., Xu, Y., Miao, S., Yao, G., Xue, Y., Geng, J., Jin, X., Meng, H."MicroRNA‑650 targets inhibitor of growth 4 to promote colorectal cancer progression via mitogen activated protein kinase signaling". Oncology Letters 16, no. 2 (2018): 2326-2334. https://doi.org/10.3892/ol.2018.8910